Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CH:ROG
Stock Latest News
The Fly
Roche says 760 ambulatory DMD patients treated with Elevidys with no deaths
12h ago
CHRO
SRPT
Premium
The Fly
Roche says set to resume shipments of Sarepta’s Elevidys outside U.S.
12h ago
CHRO
SRPT
Premium
The Fly
Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
1d ago
AZN
BMY
Premium
The Fly
Roche price target raised to CHF 230 from CHF 220 at JPMorgan
1d ago
CHRO
Premium
The Fly
Genentech to present new data from Alzheimer’s development portfolio
2d ago
CHRO
Premium
The Fly
Roche plans to test if new medicine can prevent AD symptoms, Bloomberg says
2d ago
CHRO
Premium
The Fly
Roche says will work with EMA on path forward for Elevidys
5d ago
CHRO
SRPT
Premium
The Fly
European Union committee recommends against Sarepta’s Elevidys
5d ago
CHRO
SRPT
Premium
The Fly
Brazil suspends sales of Sarepta’s Elevidys after deaths
5d ago
CHRO
SRPT
Premium
Company Announcements
Roche Reports Strong Sales Growth in H1 2025
5d ago
Premium
The Fly
Sarepta price target lowered to $35 from $40 at Jefferies
6d ago
CHRO
SRPT
Premium
The Fly
Roche says Brazilian death unrelated to Elevidys, Bloomberg reports
6d ago
CHRO
SRPT
Premium
The Fly
Roche says Elevidys benefit-risk in ambulatory patients remains positive
6d ago
CHRO
SRPT
Premium
The Fly
H.C. Wainwright sees rejection for Sarepta in Europe tomorrow
6d ago
CHRO
SRPT
Premium
Ratings
Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges
6d ago
CHRO
Premium
The Fly
Roche reports 1H group sales CHF 30.9B vs. CHF 29.8B last year
6d ago
CHRO
Premium
The Fly
Roche sees FY25 core EPS growing in high single digit range
6d ago
CHRO
Premium
The Fly
Roche receives CE Mark for Elecsys pTau181
7d ago
LLY
CHRO
Premium
The Fly
Roche pauses shipments of Elevidys outside the U.S., Bloomberg says
7d ago
CHRO
Premium
The Fly
Roche announces European Commission approved Itovebi
7d ago
CHRO
Premium
The Fly
Roche announces ALIENTO trial meets, ARNASA study misses primary endpoint
9d ago
CHRO
Premium
The Fly
Genetech: STARGLO data does not provide sufficient evidence for DLBCL indication
11d ago
CHRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.